New Jersey · 2026-2027 Regular Session · Bill

S 446: Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.

In committee Last action January 13, 2026: Introduced in the Senate, Referred to Senate Commerce Committee

Plain-language summary

S 446 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products. Primary sponsor: Brian Stack (Democratic). Most recent recorded action (January 13, 2026): Introduced in the Senate, Referred to Senate Commerce Committee.

Sponsors

Primary sponsor: Brian Stack (Democratic).